Rockwell Medical RMTI
NASDAQ RMTI
$7.64 +0.14 (+1.87%)
At close: Aug 20, 2026 · 4:00 PM EDT

Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025)

Rockwell Medical's (RMTI) quarterly Total Non-Current Liabilities came in at $20.2 million in Q4 2025, down 21.3% YoY from $25.6 million in Q4 2024, and down 1.48% on a QoQ basis from $20.5 million in Q3 2025.

Rockwell Medical (RMTI) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

Rockwell Medical (RMTI) has 11 years of Total Non-Current Liabilities data on file, last reported at $20.2 million in Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 21.3% year-over-year to $20.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $20.2 million (down 21.3% YoY) and the FY2025 annual result came in at $20.2 million, down 21.3% from the prior year.
  • Total Non-Current Liabilities retreated to $20.2 million in Q4 2025, from $20.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $46.0 million in Q4 2021 to a low of $20.2 million in Q4 2025.
  • A 5-year average of $30.1 million and a median of $28.6 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Total Non-Current Liabilities sank 33.89% — and 2024, when it rose 7.7%.
  • Tracing RMTI's Total Non-Current Liabilities over 5 years: stood at $46.0 million in 2021, then slipped by 29.32% to $32.5 million in 2022, then retreated by 5.11% to $30.9 million in 2023, then fell by 16.99% to $25.6 million in 2024, then retreated by 21.3% to $20.2 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $20.2 million (Q4 2025), $20.5 million (Q3 2025), and $22.2 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -13.28 Bn
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 16.45 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 11.64 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 33.50 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 607.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 18.76 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 1.37 Bn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 6.42 Bn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - 334.00 Mn
10 Rockwell Medical 30.62 Mn 5.82 Mn 3.24 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 20.16 Mn
Sep 30, 2025 20.47 Mn
Jun 30, 2025 22.22 Mn
Mar 31, 2025 21.94 Mn
Dec 31, 2024 25.62 Mn
Sep 30, 2024 27.94 Mn
Jun 30, 2024 29.52 Mn
Mar 31, 2024 30.07 Mn
Dec 31, 2023 30.87 Mn
Sep 30, 2023 28.59 Mn
Jun 30, 2023 28.50 Mn
Mar 31, 2023 27.92 Mn
Dec 31, 2022 32.53 Mn
Sep 30, 2022 38.04 Mn
Jun 30, 2022 38.96 Mn
Mar 31, 2022 42.23 Mn
Dec 31, 2021 46.03 Mn
Dec 31, 2020 43.58 Mn
Sep 30, 2014 19.65 Mn
Jun 30, 2014 21.66 Mn